Affiliation:
1. Pharma fur Alle, Basel, Switzerland
Abstract
Drug company marketing scandals have often made headlines. However, in recent years, a raft of new pharmaceutical industry transgressions has created crises for health care systems of high-income countries as well as poorer nations. Prices of life-saving drugs are soaring; supply shortfalls of essential medications have become common; development of new antibiotics against resistant organisms is lagging; and inequalities in access to medicines are widening. Policymakers must find new solutions to protect health systems and health.
Reference12 articles.
1. Brown D. Medicine For All. The case for a public option in the pharmaceutical industry, Executive Summary. 2018. Available from: https://democracycollaborative.org/learn/ publication/medicine-all-case-public-option-pharmaceutical-industry. Accessed May 24, 2022
2. Healing an ailing pharmaceutical system: prescription for reform for United States and Canada
3. Ringger B. Pharma fürs Volk, Rotpunkt-Verlag, Zürich, 2022. Page 72.
4. Entwicklung der Arzneimittelkosten und -preise in der Versorgung
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献